Veterinary Medicines

Xylapan 20 mg/ml - Injektionslösung für Tiere

Authorised
  • Xylazine hydrochloride
Download as PDF

Product identification

Medicine name:
Xylapan 20 mg/ml - Injektionslösung für Tiere
Active substance:
  • Xylazine hydrochloride
Target species:
  • Cattle
  • Dog
  • Cat
  • Horse
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Xylazine hydrochloride
    23.30
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Milk
        0
        hour
      • Meat and offal
        1
        day
    • Dog
    • Cat
  • Intravenous use
    • Dog
    • Horse
      • Meat and offal
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN05CM92
Legal status of supply:
  • Medicinal product on medical prescription for renewable delivery
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetoquinol Oesterreich GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol Biowet Sp. z o.o.
Responsible authority:
  • AGES
Authorisation number:
  • 8-00359
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 11/01/2021
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 24/01/2019
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 24/01/2019
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."